Contribution of Fas to diabetes development
- 13 January 2003
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 100 (2) , 628-632
- https://doi.org/10.1073/pnas.0237359100
Abstract
Fas (Tnfrsf6, Apo-1, CD95) is a death receptor involved in apoptosis induced in many cell types. Fas have been shown to be expressed by insulin-producing beta cells in mice and humans. However, the importance of Fas in the development of autoimmune diabetes remains controversial. To further evaluate the importance of Fas in pathogenesis of diabetes, we generated NOD mice (nonobese diabetic mice developing spontaneous autoimmune diabetes) with beta cell-specific expression of a dominant-negative point mutation in a death domain of Fas, known as lprcgor Fascg. Spontaneous diabetes was significantly delayed in NOD mice expressing Fascg, and the effect depended on the expression level of the transgene. However, Fascg-bearing mice were still sensitive to diabetes transferred by splenocytes from overtly diabetic NOD mice. At the same time, Fascgexpression did neutralize the accelerating effect of transgenic Fas-ligand expressed by the same beta cells. Thus, both Fas-dependent and -independent mechanisms are involved in beta cell destruction, but interference with the Fas pathway early in disease development may retard or prevent diabetes progression.Keywords
This publication has 36 references indexed in Scilit:
- Staining Pattern of the Brush Border and Detection of Cytoplasmic Granules in the Uriniferous Tubules of Female DBA/2Cr Mouse Kidney: Comparison among Various Fixations and Stains.The Journal of Veterinary Medical Science, 2001
- Proinflammatory consequences of transgenic Fas ligand expression in the heartJournal of Clinical Investigation, 2000
- The Role of CD4 vs. CD8 T Cells in IDDMJournal of Autoimmunity, 1999
- Insulin-Dependent Diabetes MellitusCell, 1996
- CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells.The Journal of Experimental Medicine, 1996
- Distinctive Expression of Iprcg in the Heterozygous State on Different Genetic BackgroundsCellular Immunology, 1993
- Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosisNature, 1992
- A new allele of the lpr locus, lprcg, that complements the gld gene in induction of lymphadenopathy in the mouse.The Journal of Experimental Medicine, 1990
- Diabetes and tolerance in transgenic mice expressing class II MHC molecules in pancreatic beta cellsCell, 1988
- Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseBiochemistry, 1979